Dendreon Corp. (NASDAQ: DNDN) was all over the map last year, is their pipeline for real or hype?
Dec 28, 2007 by NJ Gold | Posted in Investing
What do you reckon on from them in 2008?
52wk Range: 3.57 - 25.25
http://finance.yahoo.com/q?s=dndn
I never saw it at 25...but it was in the lofty teens for awhile...it definitely was overpriced there.
According to a couple of Fast Money guys, it does have a expected ... real products and takeover possibilities... 6 or 7 could be a nice price....could
jebediabartlett | Dec 31, 2007
I never saw it at 25...but it was in the high teens for awhile...it decidedly was overpriced there.
According to a couple of Fast Money guys, it does have a future ... real products and takeover possibilities... 6 or 7 could be a discriminating price....could
jebediabartlett | Dec 31, 2007
News Update: Dendreon (NASDAQ:DNDN) Jumps on Provenge Prostate Treatment Success
3/4/2010-Shares of Dendreon (NASDAQ:DNDN) are trading 3.9% higher to $34.94 Thursday after the anaesthetize developer said yesterday that its experimental ...
News Update: Dendreon (NASDAQ:DNDN) Up 1213.5% in One Year
Dendreontraded in a distance yesterday that spanned from a low of $39.65 to a high of $54.58. Yesterday's high of the day pierced the 3-day high ...
Dendreon Corporation is a biotechnology performers focused on the finding, evolution and commercialization of therapeutics that may rally cancer treatment options for patients.
Celgene Corporation is an integrated biopharmaceutical concern pre-eminently plighted in the uncovering, advance and commercialization of therapies designed to study cancer and inoculated-traitorous agnate diseases.
Celgene Corporation is an integrated biopharmaceutical performers in the first instance wrapped up in the ascertaining, increment and commercialization of therapies designed to care of cancer and unsusceptible-seditious correlated diseases.
DNDN (NASDAQ:DNDN) Reports Earnings: A Stellar Stock Story, Plenty ...
by VFCs Stock House
That said, Provenge sales increased from $20 to $24 million section-over-clemency, although losses also grew significantly, but again, that is in the long run attributed to bringing the manufacturing plants on path.
Top 10 Mid-Cap Stocks with Highest Upside: LEA, BCA, AGO, DNDN ...
by Investor's Resources
Lear Corporation (NYSE:LEA) has the 1st highest upside future in this subdivide of the sell. Its upside is 116.1%. Its consensus butt sacrifice is $105.97 based...
SEATTLE, May 21, 2012 (Dealing WIRE) -- May 21, 2012--Dendreon Corporation (NASDAQ:DNDN) today announced the following PROVENGE(R) (sipuleucel-T) matter will be presented at the American Urological Association (AUA) Annual Meeting taking place May 19
Dell Inc. (NASDAQ: DELL) had its “parallel weight” rating re-affirmed by analysts at Morgan Stanley. They now have a $16.00 price target on the stockpile, down previously from $18.00. Dendreon Co. (NASDAQ: DNDN) had its “hold” rating re-affirmed by analysts
Shares in Dendreon Corporation (NASDAQ:DNDN) dropped over 4.97% in last trading day, and reasons could cover a SEC investigation into the Seattle biotech and the victory of a competitor's prostate cancer drug. In Friday trading, Dendreon shares were
Dec 06, 2011 from DJ Thistle
Dendreon Raising $125 Million Via I.P. Trafficking (DNDN, MRK): Dendreon Corporation (NASDAQ: DNDN) is supposed to be t...
Dec 06, 2011 from Wikileaksstocks
Dendreon Agrees to Blow the whistle on VICTRELIS Royalty Interest for $125 Million: Dendreon Corporation (NASDAQ: DNDN) today a...
Dec 06, 2011 from Best Finance Blog
Dendreon Raising $125 Million Via I.P. Buying (DNDN, MRK): Dendreon Corporation (NASDAQ: DNDN) is supposed to be t...